ERBB2 and neoplasm: Interestingly, HER2 was evaluated also by immunofluorescence using CellSearch®, and the 3D–IF–FISH method detected a higher number of cases with HER2-negative primary tumor, but HER2-positive CTCs compared to CellSearch®.